The Independent Voice of
European Private Equity

Advanced Search

GED Capital makes 4x on Vitro exit

Simon Thompson 9 March 2022

molecular_Molecular
  • GED Capital's exit achieved a 4x return and 38 per cent IRR.
  • Under GED’s hold, Vitro maximised the business’ value and better positioned each of its subsidiaries.
  • ...

Related Articles

Inflexion-backed Detectortesters expands in the US with new acquisition

17/05/24

Fund in Focus: Headway Capital renews emphasis on deal-by-deals through latest fund

17/05/24

Polaris picks up InArea Group minority stake

17/05/24

Argos Wityu acquires German bakery chain

17/05/24

Aksia sells Italian bakery portco to Wise Equity

17/05/24

Inflexion backs training and nutrition programme provider Ultimate Performance

17/05/24